aTYR PHARMA INC Liquidation Value

ATYR Other

Cash & Equivalents

$10.74M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $10.74M
Total Obligations: -$27.18M
$-16.44M
Per share: $-0.17
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $10.74M
AR: $873,000
Total Obligations: -$27.18M
$-15.56M
Per share: $-0.16
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $10.74M
AR: $873,000
Inventory: $0
Total Obligations: -$27.18M
$-15.56M
Per share: $-0.16
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-16.44M$-0.17
Liquid Liquidation Value$-15.56M$-0.16
Operating Liquidation Value$-15.56M$-0.16

Key Components (as of 2025-12-31)

Cash & Equivalents$10.74M
Accounts Receivable$873,000
InventoryN/A
Current Liabilities$15.15M
Long-term DebtN/A
Op. Lease Liability$11.14M
Finance Lease$889,000
Shares Outstanding98.0M

Explore all 157 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$10.74M$873,000N/A$3.89M$15.15MN/A$11.14M$889,000
2025-09-30$6.15M$1.04MN/A$4.06M$15.68MN/A$11.33M$1.03M
2025-06-30$17.22M$498,000N/A$3.88M$15.53MN/A$11.51M$1.16M
2025-03-31$10.36M$988,000N/A$1.53M$10.68MN/A$11.69M$1.30M

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-05 View
2025-09-30 10-Q 2025-11-06 View
2025-06-30 10-Q 2025-08-07 View
2025-03-31 10-Q 2025-05-07 View
2024-12-31 10-K 2025-03-13 View
2024-09-30 10-Q 2024-11-07 View
2024-06-30 10-Q 2024-08-13 View
2024-03-31 10-Q 2024-05-02 View

Community Notes

Loading notes...

Questions

Loading questions...